Osama Sabri Selected Research

2beta- carbomethoxy- 3beta- (4- iodophenyl)tropane (Iometopane)

1/2006	Serotonin transporter imaging with [123I]beta-CIT SPECT before and after one year of citalopram treatment of obsessive-compulsive disorder.
8/2004	Reduced serotonin transporter-availability in obsessive-compulsive disorder (OCD).
2/2003	Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease.
8/2002	Correlation between automated writing movements and striatal dopaminergic innervation in patients with Wilson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Osama Sabri Research Topics

Disease

49	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 11/2003
36	Dementia (Dementias) 01/2022 - 03/2008
22	Cognitive Dysfunction 01/2022 - 03/2008
14	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022 - 03/2006
10	Obesity 12/2020 - 01/2013
8	Parkinson Disease (Parkinson's Disease) 02/2021 - 05/2004
8	Atrophy 12/2020 - 01/2013
8	Neoplasms (Cancer) 05/2020 - 04/2003
7	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 12/2017 - 06/2010
7	Amyloid Plaque 11/2017 - 04/2006
5	Hodgkin Disease (Hodgkin's Disease) 10/2018 - 08/2006
4	Tauopathies 01/2022 - 01/2019
4	Weight Loss (Weight Reduction) 11/2021 - 01/2016
4	Hypoxia (Hypoxemia) 01/2019 - 04/2003
4	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 06/2011 - 08/2004
3	Disease Progression 01/2022 - 01/2018
3	Lymphoma (Lymphomas) 09/2021 - 01/2021
3	Corticobasal Degeneration 05/2021 - 01/2017
3	Pulmonary Hypertension 01/2021 - 01/2005
3	Neurobehavioral Manifestations 01/2021 - 08/2015
3	Multiple Sclerosis 01/2021 - 05/2014
3	Squamous Cell Carcinoma of Head and Neck 01/2019 - 01/2015
3	Body Weight (Weight, Body) 01/2018 - 01/2016
3	Death (Near-Death Experience) 01/2017 - 06/2016
2	Morbid Obesity 11/2021 - 01/2017
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 01/2021
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021 - 11/2020
2	Fatigue 01/2021 - 01/2020
2	Hyperthyroidism 01/2021 - 12/2016
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2019 - 02/2009
2	Movement Disorders (Movement Disorder) 07/2019 - 08/2008
2	Frontotemporal Dementia (Semantic Dementia) 01/2019 - 05/2015
2	Hyperphagia (Overeating) 06/2017 - 01/2013
2	Parkinsonian Disorders (Parkinsonism) 07/2016 - 01/2013
2	Depressive Disorder (Melancholia) 09/2015 - 08/2009
2	Glioma (Gliomas) 08/2014 - 01/2008
2	Hepatolenticular Degeneration (Wilson's Disease) 04/2012 - 08/2002
2	Thyroid Diseases (Thyroid Disease) 04/2009 - 08/2005
2	Myocardial Infarction 10/2005 - 03/2004
2	Coronary Artery Disease (Coronary Atherosclerosis) 07/2005 - 03/2004
2	Stroke (Strokes) 01/2005 - 03/2004
1	Infections 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 09/2021
1	Delusional Parasitosis 05/2021
1	Tremor (Tremors) 02/2021

Drug/Important Bio-Agent (IBA)

35	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2011
26	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
17	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2021 - 01/2011
15	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 01/2005
13	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 04/2008
9	Serotonin (5 Hydroxytryptamine)IBA 12/2020 - 11/2003
8	Amyloid beta-PeptidesIBA 01/2022 - 04/2006
8	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2021 - 08/2004
8	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021 - 03/2006
7	Cholinergic Agents (Cholinergics)IBA 01/2022 - 11/2003
7	Pharmaceutical PreparationsIBA 01/2018 - 08/2004
6	N-acetyltalosaminuronic acid (NAT)IBA 11/2021 - 06/2017
6	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 02/2021 - 10/2005
5	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2021 - 01/2018
4	Apolipoproteins E (ApoE)IBA 01/2022 - 05/2011
4	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2019
4	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2021 - 11/2003
4	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 02/2021 - 02/2009
4	fluoronorchloroepibatidineIBA 01/2021 - 04/2013
4	2beta- carbomethoxy- 3beta- (4- iodophenyl)tropane (Iometopane)IBA 01/2006 - 08/2002
3	tau Proteins (tau Protein)IBA 01/2022 - 01/2019
3	Deoxyglucose (2 Deoxy D glucose)IBA 09/2021 - 10/2005
3	LigandsIBA 01/2021 - 03/2008
3	Biological ProductsIBA 07/2019 - 05/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2019
3	Neurotransmitter Agents (Neurotransmitter)IBA 06/2017 - 11/2003
2	PrionsIBA 01/2022 - 07/2019
2	Cholinergic ReceptorsIBA 01/2022 - 03/2008
2	1'- benzyl- 3- (2- fluoroethyl)- 3H- spiro((2)benzofuran- 1,4'- piperidine)IBA 01/2021 - 05/2020
2	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 01/2021 - 12/2020
2	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2013
2	Citalopram FDA LinkGeneric 01/2019 - 01/2006
2	Tumor Suppressor Protein p53IBA 01/2019 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2019
2	Indicators and Reagents (Reagents)IBA 07/2017 - 08/2015
2	3- iodo- 2- hydroxy- 6- methoxy- N- ((1- ethyl- 2- pyrrolidinyl)methyl)benzamideIBA 08/2008 - 02/2003
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 04/2008 - 10/2005
2	2-fluoro-3-(2-azetidinylmethoxy)pyridineIBA 03/2008 - 03/2008
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 04/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	EnzymesIBA 01/2022
1	Yttrium-90IBA 01/2022
1	3- (1,4- diazabicyclo(3.2.2)nonan- 4- yl)- 6- fluorodibenzo(b,d)thiophene 5,5-dioxideIBA 01/2022
1	Anaplastic Lymphoma KinaseIBA 09/2021
1	Valproic Acid (Depakote)FDA LinkGeneric 05/2021

Therapy/Procedure

11	Therapeutics 01/2022 - 07/2005
7	Drug Therapy (Chemotherapy) 01/2021 - 08/2006
2	Deep Brain Stimulation 02/2021 - 07/2008
2	Transplantation 01/2021 - 10/2005
2	Induction Chemotherapy 10/2018 - 01/2017
2	Bariatric Surgery 01/2017 - 01/2016
2	Radiotherapy 01/2017 - 01/2008
1	Arthroplasty 01/2022
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 11/2021